130 related articles for article (PubMed ID: 25104196)
1. Incremental (?) role of positron emission tomography/computed tomography in clinically unknown primary patients with neck metastasis.
Mohindra S; Bhattacharya A; Goshal S; Gupta B
Indian J Cancer; 2014; 51(2):142-4. PubMed ID: 25104196
[TBL] [Abstract][Full Text] [Related]
2. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
[TBL] [Abstract][Full Text] [Related]
4. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup.
Waltonen JD; Ozer E; Hall NC; Schuller DE; Agrawal A
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1024-9. PubMed ID: 19841343
[TBL] [Abstract][Full Text] [Related]
5. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
6. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
7. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
9. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
[TBL] [Abstract][Full Text] [Related]
10. [The correlation of positron emission tomography-computed tomography assessment with histopathological results in the diagnosis of head and neck cancer of unknown primary].
Inan IE; Kılıç C; Tunçel U
Kulak Burun Bogaz Ihtis Derg; 2012; 22(6):319-23. PubMed ID: 23176695
[TBL] [Abstract][Full Text] [Related]
11. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography in the management of unknown primary head and neck carcinoma.
Miller FR; Hussey D; Beeram M; Eng T; McGuff HS; Otto RA
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):626-9. PubMed ID: 16027287
[TBL] [Abstract][Full Text] [Related]
13. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
14. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
Stoeckli SJ; Mosna-Firlejczyk K; Goerres GW
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):411-6. PubMed ID: 12634970
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy response in head and neck cancer - evaluation of the primary tumour site.
Sjövall J; Brun E; Almquist H; Kjellén E; Wahlberg P
Acta Otolaryngol; 2014 Jun; 134(6):646-51. PubMed ID: 24707930
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial.
Rudmik L; Lau HY; Matthews TW; Bosch JD; Kloiber R; Molnar CP; Dort JC
Head Neck; 2011 Jul; 33(7):935-40. PubMed ID: 21674668
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of unknown primary in the head and neck: comparison between positron emission tomography (PET) and PET/CT.
Keller F; Psychogios G; Linke R; Lell M; Kuwert T; Iro H; Zenk J
Head Neck; 2011 Nov; 33(11):1569-75. PubMed ID: 21990221
[TBL] [Abstract][Full Text] [Related]
19. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
20. PET/CT in the management of metastatic cervical lymphadenopathy from unknown primary site: a seven years retrospective study.
Barbosa M; Duarte H; Breda E; Monteiro E
Rev Laryngol Otol Rhinol (Bord); 2013; 134(2):89-94. PubMed ID: 24683818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
